Tarrabain Alex 5/A
5/A · CEN BIOTECH INC · Filed May 28, 2021
Insider Transaction Report
Form 5/AAmended
CEN BIOTECH INCCENBF
Tarrabain Alex
DirectorChief Financial Officer
Transactions
- Award
Common Stock
2017-11-30+20,000→ 99,942 total
Footnotes (2)
- [F1]20,000 shares of common stock of the issuer were granted by the issuer on November 30, 2017, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
- [F2]99,942 shares were beneficially owned by the Reporting Person of which 30,000 shares were issuable upon conversion of a convertible note held by the Reporting Person at 12/31/2017.